Back to Scanner
APLS
NASDAQRS 1Score 25Apellis Pharmaceuticals, Inc.
HealthcareBiotechnology$5.17B1 setup passing
$40.41
0.0% ($0.00)
-0.2% from 52W High
P/E (TTM)
227.50
Fwd P/E
—
PEG
—
Analyst Upside
-35.7%
EPS Growth
—
Gross Margin
89.8%
ROE
8.2%
D/E
1.31
Div Yield
0.0%
Avg Volume
10.3M
Price Chart
Key Levels
SMA 200
$22.64
SMA 50
$21.49
Price
$40.41
52W High
$40.49
Target
$26.00
Setup Radar
1/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst